The Firm Will Exhibit Via a Digital Sales space to Current its Merchandise, Product Strains, and Enterprise Initiatives to a Broad Array of High Tier Institutional Biotech Traders
NEW YORK, NY, Dec. 31, 2020 (GLOBE NEWSWIRE) — via NewMediaWire— Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Firm”), a income producing, diversified life sciences firm, with a proprietary line of practical “complement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) in addition to two ongoing Biotechnologies initiatives, at the moment introduced that it has been authorized to be a Company Exhibitor on the 5th Annual CTIC Capital Pre-J.P. Morgan (“Pre-JPM”) Healthcare Funding Summit (the “Summit”). The Firm may have the chance to current its merchandise, product strains, enterprise initiatives, and strategic plan for 2021 – to a broad array of prime tier institutional biotech buyers.
Hyperlink to CTIC 5th Annual Pre-JPM Healthcare Funding Summit:
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a income producing, diversified life sciences firm, engaged in a number of main enterprise actions and initiatives. The corporate manufactures and distributes a number of proprietary retail merchandise and product strains, primarily centered on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market section. The principle product line, branded as Tauri-Gum™, consists of a proprietary complement chewing gum that’s Kosher licensed, Halal licensed, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Tauri-Gum™ Taste: Pear Bellini). The Firm’s commercialization technique consists of a broad array of retail prospects, distributors, and a fast-growing E-Commerce enterprise section (E-Commerce web site: www.taurigum.com). Please go to our company web site, for extra data, in addition to inquiries, at http://www.tauriga.com
Complementary to the Firm’s retail enterprise, are its two ongoing biotechnology initiatives. The primary one pertains to the event of a Pharmaceutical grade model of Tauri-Gum™, for nausea regulation (particularly designed to assist sufferers which can be subjected to ongoing chemotherapy remedy). On March 18, 2020, the Firm introduced that it filed a provisional U.S. patent utility protecting its pharmaceutical grade model of Tauri-Gum™. The Patent, filed with the united statesP.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second pertains to a collaboration settlement with Aegea Biotechnologies Inc. for the co-development of a speedy, multiplexed, Novel Coronavirus (COVID-19) check with superior sensitivity and selectivity.
On October 6, 2020, the Firm introduced that it has been authorized to function as a U.S. Authorities Vendor (CAGE CODE # 8QXV4)
On October 7, 2020 the Firm disclosed a Strategic Alliance with Suppose BIG, LLC, Social Impression Startup Based by CJ Wallace, Son of Christopher “The Infamous B.I.G.” Wallace.
The Firm is headquartered in New York Metropolis and operates a regional workplace in Barcelona, Spain. As well as, the Firm operates a full time E-Commerce success heart situated in LaGrangeville, New York.
DISCLAIMER — Ahead-Wanting Statements
This press launch incorporates sure “forward-looking statements” as outlined by the Personal Securities Litigation Reform Act of 1995 which signify administration’s beliefs and assumptions regarding future occasions. These forward-looking statements are sometimes indicated through the use of phrases resembling “might,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and should embody statements concerning company goals in addition to the attainment of sure company targets and milestones. Ahead-looking statements are primarily based on current circumstances and on administration’s current beliefs with respect to occasions that haven’t occurred, that won’t happen, or which will happen with completely different penalties or timing than these now assumed or anticipated. Precise outcomes might differ materially from these expressed in ahead wanting statements resulting from identified and unknown dangers and uncertainties, resembling will not be ensures of normal financial and enterprise situations, the flexibility to efficiently develop and market merchandise, client and enterprise consumption habits, the flexibility to consummate profitable acquisition and licensing transactions, fluctuations in alternate charges, and different components over which Tauriga has little or no management. Many of those dangers and uncertainties are mentioned in higher element within the “Threat Elements” part of Tauriga’s Type 10-Okay and different filings made once in a while with the Securities and Alternate Fee. Such forward-looking statements are made solely as of the date of this launch, and Tauriga assumes no obligation to replace forward-looking statements to replicate subsequent occasions or circumstances. You shouldn’t place undue reliance on these forward-looking statements.
Tauriga Sciences, Inc.
555 Madison Avenue, fifth Flooring
New York, NY 10022
Chief Govt Officer
Mr. Seth M. Shaw
E mail: email@example.com
cell # (917) 796 9926
Corp. Web site: www.tauriga.com
E-Commerce Web site: www.taurigum.com